ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety

被引:73
作者
Kohan, Alison B. [2 ]
Wang, Fei [1 ]
Lo, Chun-Min [1 ]
Liu, Min [1 ]
Tso, Patrick [1 ]
机构
[1] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH USA
[2] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2015年 / 308卷 / 06期
基金
美国国家卫生研究院;
关键词
apolipoprotein A-IV (apoA-IV); chylomicron; intestinal lipid transport; lymph fistula mouse model; satiety; diabetes; obesity; cardiovascular disease; glucose homeostasis; APOLIPOPROTEIN-A-IV; GASTRIC BYPASS-SURGERY; TRIGLYCERIDE-RICH LIPOPROTEINS; CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; RAT HYPOTHALAMUS; GENE-EXPRESSION; VAGAL AFFERENT; LEPTIN ACTION; HUMAN-PLASMA;
D O I
10.1152/ajpgi.00098.2014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Apolipoprotein A-IV (apoA-IV) is secreted by the small intestine on chylomicrons into intestinal lymph in response to fat absorption. Many physiological functions have been ascribed to apoA-IV, including a role in chylomicron assembly and lipid metabolism, a mediator of reverse-cholesterol transport, an acute satiety factor, a regulator of gastric function, and, finally, a modulator of blood glucose homeostasis. The purpose of this review is to update our current view of intestinal apoA-IV synthesis and secretion and the physiological roles of apoA-IV in lipid metabolism and energy homeostasis, and to underscore the potential for intestinal apoA-IV to serve as a therapeutic target for the treatment of diabetes and obesity-related disease.
引用
收藏
页码:G472 / G481
页数:10
相关论文
共 104 条
[11]   Apolipoprotein A-IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass [J].
Culnan, Derek M. ;
Cooney, Robert N. ;
Stanley, Bruce ;
Lynch, Christopher J. .
OBESITY, 2009, 17 (01) :46-52
[12]  
Curtin A, 1996, ACTA DIABETOL, V33, P205
[13]  
DEBAS HT, 1975, GASTROENTEROLOGY, V68, P1211
[14]   Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding [J].
Doi, T ;
Liu, M ;
Seeley, RJ ;
Woods, SC ;
Tso, P .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 281 (03) :R753-R759
[15]   Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48 - Containing lipoproteins in humans [J].
Duez, Helene ;
Lamarche, Benoit ;
Uffelman, Kristine D. ;
Valero, Rene ;
Cohn, Jeffrey S. ;
Lewis, Gary F. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (06) :1357-1363
[16]   Protection against atherogenesis in mice mediated by human apolipoprotein A-IV [J].
Duverger, N ;
Tremp, G ;
Caillaud, JM ;
Emmanuel, F ;
Castro, G ;
Fruchart, JC ;
Steinmetz, A ;
Denefle, P .
SCIENCE, 1996, 273 (5277) :966-968
[17]   Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action [J].
Ebihara, K ;
Ogawa, Y ;
Katsuura, G ;
Numata, Y ;
Masuzaki, H ;
Satoh, N ;
Tamaki, M ;
Yoshioka, T ;
Hayase, M ;
Matsuoka, N ;
Aizawa-Abe, M ;
Yoshimasa, Y ;
Nakao, K .
DIABETES, 1999, 48 (10) :2028-2033
[18]   Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non-apolipoprotein B-containing lipoproteins in obese women [J].
Ferrer, F ;
Nazih, H ;
Zaïr, Y ;
Krempf, M ;
Bard, JM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (12) :1537-1541
[19]  
Ferrer F, 2002, CLIN CHEM, V48, P884
[20]   LEPTIN LEVELS REFLECT BODY LIPID-CONTENT IN MICE - EVIDENCE FOR DIET-INDUCED RESISTANCE TO LEPTIN ACTION [J].
FREDERICH, RC ;
HAMANN, A ;
ANDERSON, S ;
LOLLMANN, B ;
LOWELL, BB ;
FLIER, JS .
NATURE MEDICINE, 1995, 1 (12) :1311-1314